Recently opened studies

Trial Name

Description

Click for further information (external page)

Date opened

C34004

Phase 2 Study of TAK-659 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Suitable for patients with lymphoma which has come back after previous treatment

October 2017

JAVELIN DLBCL

A phase 1/3 trial testing a new drug avelumab.

Suitable for patients with lymphoma which has come back after previous treatment

October 2017

PQR309-005

A phase 2 trial testing a targeted drug, PQR309.

Suitable for patients with CNS (brain) lymphoma which has come back after previous treatment

November 2017

INCYTE (CITADEL-202)

A phase 2 trial testing a new drug, INCB050465

Suitable for patients with Diffuse Large B cell lymphoma which has come back after previous treatment.

October 2017